Alzheimer’s disease market expected to reach $13.7bn across the 8MM by 2030

The Alzheimer’s disease (AD) market is expected to grow at a compound annual growth rate (CAGR) of 20.0% over the course of the forecast period (2020–2030), reaching $13.7bn across the eight major markets (8MM) (US, France, Germany, Italy, Spain, UK, Japan, and China), according to GlobalData’s recent report, Alzheimer’s Disease: Eight-Market Drug Forecast and Market Analysis.